Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cagatay Taskiran

Showing results (81-90 of 101) with videos related to

Pageof 11
Sort By:
Cancers|April 14, 2026
Long-Term Young Adult Cancer Survivors with Ovarian Cancer: Subgroup Analysis of the Study "Expression VI-Carolin Meets HANNA-Holistic Analysis of Long-Term Survival with Ovarian Cancer": The International NOGGO, ENGOT, and GCIG SurveyDesislava Dimitrova, Eleftherios Pierre Samartzis, Dario Zocholl, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 30, 2026
The PROMISE-EC Study: prognostic role of molecular classification and sentinel lymph node status in early-stage endometrial cancerFrancesco Fanfani, Ilaria Capasso, Jessica Mauro, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 13, 2015
European Network of Gynaecological Oncological Trial Groups' Requirements for Trials Between Academic Groups and Industry Partners--First Update 2015Andreas du Bois, Alexander Reuss, Eric Pujade-Lauraine, et al.
Current Oncology (Toronto, Ont.)|December 13, 2021
Could the Long-Term Oncological Safety of Laparoscopic Surgery in Low-Risk Endometrial Cancer also Be Valid for the High-Intermediate- and High-Risk Patients? A Multi-Center Turkish Gynecologic Oncology Group Study Conducted with 2745 Endometrial Cancer Cases. (TRSGO-End-001)Mehmet Ali Vardar, Ahmet Baris Guzel, Salih Taskin, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 31, 2025
SLYMEC II study: Overall survival analysis of the impact of LVSI in apparent early stage endometrioid endometrial cancerJessica Mauro, Michael Mueller, Emanuele Perrone, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 17, 2024
The impact of Substantial LYMphovascular space invasion on sentinel lymph nodes status and recurrence in Endometrial Cancer patients: SLYM-EC a multicenter retrospective studyAlessandro Buda, Robert Fruscio, Jessica Mauro, et al.
Cancers|April 13, 2023
The Risk of Recurrence in Endometrial Cancer Patients with Low-Volume Metastasis in the Sentinel Lymph Nodes: A Retrospective Multi-Institutional StudyAlessandro Buda, Cristiana Paniga, Salih Taskin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 3, 2023
Influence of Genomic Landscape on Cancer Immunotherapy for Newly Diagnosed Ovarian Cancer: Biomarker Analyses from the IMagyn050 Randomized Clinical TrialCharles N Landen, Luciana Molinero, Habib Hamidi, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 20, 2026
Pelvic exenteration for vulvar cancer: contemporary outcomes from a multinational cohort studyDiana Zach, Denis Querleu, Mahmood Ul Hassan, et al.
Gynecologic Oncology|August 25, 2023
Overall survival and patient-reported outcome results from the placebo-controlled randomized phase III IMagyn050/GOG 3015/ENGOT-OV39 trial of atezolizumab for newly diagnosed stage III/IV ovarian cancerSandro Pignata, Michael Bookman, Jalid Sehouli, et al.
Pageof 11

Showing results (81-90 of 101) with videos related to

Sort By:
Pageof 11
Cancers|April 14, 2026
Long-Term Young Adult Cancer Survivors with Ovarian Cancer: Subgroup Analysis of the Study "Expression VI-Carolin Meets HANNA-Holistic Analysis of Long-Term Survival with Ovarian Cancer": The International NOGGO, ENGOT, and GCIG SurveyDesislava Dimitrova, Eleftherios Pierre Samartzis, Dario Zocholl, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 30, 2026
The PROMISE-EC Study: prognostic role of molecular classification and sentinel lymph node status in early-stage endometrial cancerFrancesco Fanfani, Ilaria Capasso, Jessica Mauro, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 13, 2015
European Network of Gynaecological Oncological Trial Groups' Requirements for Trials Between Academic Groups and Industry Partners--First Update 2015Andreas du Bois, Alexander Reuss, Eric Pujade-Lauraine, et al.
Current Oncology (Toronto, Ont.)|December 13, 2021
Could the Long-Term Oncological Safety of Laparoscopic Surgery in Low-Risk Endometrial Cancer also Be Valid for the High-Intermediate- and High-Risk Patients? A Multi-Center Turkish Gynecologic Oncology Group Study Conducted with 2745 Endometrial Cancer Cases. (TRSGO-End-001)Mehmet Ali Vardar, Ahmet Baris Guzel, Salih Taskin, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 31, 2025
SLYMEC II study: Overall survival analysis of the impact of LVSI in apparent early stage endometrioid endometrial cancerJessica Mauro, Michael Mueller, Emanuele Perrone, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 17, 2024
The impact of Substantial LYMphovascular space invasion on sentinel lymph nodes status and recurrence in Endometrial Cancer patients: SLYM-EC a multicenter retrospective studyAlessandro Buda, Robert Fruscio, Jessica Mauro, et al.
Cancers|April 13, 2023
The Risk of Recurrence in Endometrial Cancer Patients with Low-Volume Metastasis in the Sentinel Lymph Nodes: A Retrospective Multi-Institutional StudyAlessandro Buda, Cristiana Paniga, Salih Taskin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 3, 2023
Influence of Genomic Landscape on Cancer Immunotherapy for Newly Diagnosed Ovarian Cancer: Biomarker Analyses from the IMagyn050 Randomized Clinical TrialCharles N Landen, Luciana Molinero, Habib Hamidi, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 20, 2026
Pelvic exenteration for vulvar cancer: contemporary outcomes from a multinational cohort studyDiana Zach, Denis Querleu, Mahmood Ul Hassan, et al.
Gynecologic Oncology|August 25, 2023
Overall survival and patient-reported outcome results from the placebo-controlled randomized phase III IMagyn050/GOG 3015/ENGOT-OV39 trial of atezolizumab for newly diagnosed stage III/IV ovarian cancerSandro Pignata, Michael Bookman, Jalid Sehouli, et al.
Pageof 11